- Home
- CD vs CYRX Comparison
CD vs CYRX Comparison
Compare CD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CD | CYRX |
|---|---|---|
| Founded | 2011 | 1999 |
| Country | United States | United States |
| Employees | 13 | 1100 |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.5M | 419.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | CD | CYRX |
|---|---|---|
| Price | $4.68 | $14.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 203.2K | ★ 796.8K |
| Earning Date | 08-31-2023 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.09 | $6.69 |
| 52 Week High | $14.10 | $16.73 |
Technical Indicators
Market Signals| Indicator | CD | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 53.76 |
| Support Level | $4.20 | $14.29 |
| Resistance Level | $6.00 | $16.73 |
| Average True Range (ATR) | 0.96 | 0.64 |
| MACD | -0.24 | -0.24 |
| Stochastic Oscillator | 5.79 | 14.52 |
Price Performance
Historical ComparisonAbout CD Chaince Digital Holdings Inc. Ordinary Shares
Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.